Table 5 Analysis of tumor characteristics influencing MALAT1 levels in human blood
NSCLC | AdCa | SqCC | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
β | 95% CI | p value | β | 95% CI | p value | β | 95% CI | p value | ||
Intercept | -1.23 | -3.49; 1.03 | -1.23 | -3.41; 0.96 | ||||||
Tumor size (Reference: I/II) | III/IV | 1.06 | -1.28; 3.39 | 0.3670 | 1.52 | -0.82; 3.85 | 0.1911 | |||
Intercept | -0.15 | -1.11; 0.80 | -0.22 | -3.24; 2.81 | -0.14 | 1.15; 0.86 | ||||
Metastasis status (Reference: M0) | M1 | -0.14 | -1.36; 1.07 | 0.8143 | -0.46 | -3.64; 2.72 | 0.7655 | 0.65 | -0.98; 2.26 | 0.4158 |
Intercept | -0.20 | -2.48; 2.08 | 0.24 | -4.02; 4.51 | -0.42 | -3.20; 2.35 | ||||
Lymph node status (Reference: N0) | N1-N3 | -0.04 | -2.40; 2.32 | 0.9714 | -0.92 | -5.29; 3.45 | 0.6654 | 0.57 | -2.32; 3.47 | 0.6860 |